-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Keros Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q1 2025.
- Keros Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $8.86M, a 9.83% increase year-over-year.
- Keros Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $35.7M, a 14.5% increase year-over-year.
- Keros Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $34.9M, a 21.2% increase from 2023.
- Keros Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.8M, a 54% increase from 2022.
- Keros Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18.7M, a 59.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)